DK2419741T3 - Risikovurdering af antibiotikabehandling af patienter, der lider af primær ikke-infektiøs sygdom, ved bestemmelse af niveauet af procalcitonin - Google Patents
Risikovurdering af antibiotikabehandling af patienter, der lider af primær ikke-infektiøs sygdom, ved bestemmelse af niveauet af procalcitonin Download PDFInfo
- Publication number
- DK2419741T3 DK2419741T3 DK10717531T DK10717531T DK2419741T3 DK 2419741 T3 DK2419741 T3 DK 2419741T3 DK 10717531 T DK10717531 T DK 10717531T DK 10717531 T DK10717531 T DK 10717531T DK 2419741 T3 DK2419741 T3 DK 2419741T3
- Authority
- DK
- Denmark
- Prior art keywords
- determining
- infectious disease
- risk assessment
- antibiotic treatment
- primary non
- Prior art date
Links
- 208000031662 Noncommunicable disease Diseases 0.000 title 1
- 108010048233 Procalcitonin Proteins 0.000 title 1
- 230000003115 biocidal effect Effects 0.000 title 1
- CWCXERYKLSEGEZ-KDKHKZEGSA-N procalcitonin Chemical compound C([C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)NCC(O)=O)[C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@@H](N)CSSC1)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 CWCXERYKLSEGEZ-KDKHKZEGSA-N 0.000 title 1
- 238000012502 risk assessment Methods 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/575—Hormones
- G01N2333/585—Calcitonins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/325—Heart failure or cardiac arrest, e.g. cardiomyopathy, congestive heart failure
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Endocrinology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09157886 | 2009-04-14 | ||
| PCT/EP2010/002279 WO2010118855A1 (en) | 2009-04-14 | 2010-04-14 | Risk assessment for antibiotics treatment in patients suffering from primary non-infectious disease by determining the level of procalcitonin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2419741T3 true DK2419741T3 (da) | 2019-11-04 |
Family
ID=40886944
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK10717531T DK2419741T3 (da) | 2009-04-14 | 2010-04-14 | Risikovurdering af antibiotikabehandling af patienter, der lider af primær ikke-infektiøs sygdom, ved bestemmelse af niveauet af procalcitonin |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US9046532B2 (https=) |
| EP (1) | EP2419741B1 (https=) |
| JP (1) | JP5650718B2 (https=) |
| CN (2) | CN105334330A (https=) |
| CY (1) | CY1122202T1 (https=) |
| DK (1) | DK2419741T3 (https=) |
| ES (1) | ES2751105T3 (https=) |
| HK (1) | HK1221766A1 (https=) |
| HR (1) | HRP20191862T1 (https=) |
| HU (1) | HUE046182T2 (https=) |
| LT (1) | LT2419741T (https=) |
| PL (1) | PL2419741T3 (https=) |
| PT (1) | PT2419741T (https=) |
| SI (1) | SI2419741T1 (https=) |
| WO (1) | WO2010118855A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2836841B1 (en) * | 2012-04-12 | 2022-01-05 | B.R.A.H.M.S GmbH | Prognosis of adverse events in patients with suspected chronic heart failure |
| CN105528511A (zh) * | 2014-10-25 | 2016-04-27 | 潘一琦 | 一种远程诊疗对比式问诊方法及其系统 |
| CN107301319B (zh) * | 2017-06-26 | 2021-02-26 | 济南市儿童医院 | 儿科临床及科研中抗菌药物使用危险评估系统 |
| JP7444776B2 (ja) * | 2017-12-20 | 2024-03-06 | ベー．エル．アー．ハー．エム．エス ゲゼルシャフト ミット ベシュレンクテル ハフツング | 併存症を有する患者におけるプロカルシトニンに基づく抗生物質療法のガイダンス |
| EP3502706A1 (en) * | 2017-12-20 | 2019-06-26 | B.R.A.H.M.S GmbH | Workflow for risk assessment and patient management using procalcitonin and midregional-proadrenomedullin |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5314804A (en) * | 1992-03-24 | 1994-05-24 | Serim Research Corporation | Test for Helicobacter pylori |
| DE19600875C1 (de) * | 1996-01-12 | 1997-06-26 | Brahms Diagnostica Gmbh | Diagnostisches Verfahren zur Bestimmung der Ätiologie entzündlicher Prozesse |
| ATE395364T1 (de) * | 1999-12-22 | 2008-05-15 | Dade Behring Marburg Gmbh | Gegen procalcitonin gerichtete antikörper, ihre herstellung und verwendung |
| JP2005522669A (ja) * | 2001-08-20 | 2005-07-28 | バイオサイト インコーポレイテッド | 卒中および脳損傷の診断マーカーおよびその使用方法 |
| US20050148029A1 (en) * | 2003-09-29 | 2005-07-07 | Biosite, Inc. | Methods and compositions for determining treatment regimens in systemic inflammatory response syndromes |
| DE102005034174A1 (de) * | 2005-07-21 | 2007-02-08 | B.R.A.H.M.S Ag | Liquordiagnostisches in vitro Verfahren zur Diagnose von Demenz-Erkrankungen und neuroinflammatorischen Erkrankungen |
| FR2894675B1 (fr) * | 2005-12-14 | 2008-06-27 | Assist Publ Hopitaux De Paris | Distinction des meningites bacteriennes et virales |
| DE102006046996A1 (de) * | 2006-10-01 | 2008-04-03 | Brahms Aktiengesellschaft | Diagnose von Infektionen oder Entzündungserkrankungen der Atemwege und Lunge assoziiert mit Herzinsuffizienz |
| CN103123359B (zh) * | 2007-08-03 | 2015-07-29 | B.R.A.H.M.S有限公司 | 降钙素原(pct)在患原发性非传染疾病的患者的风险分级和预后中的应用 |
-
2010
- 2010-04-14 JP JP2012505086A patent/JP5650718B2/ja active Active
- 2010-04-14 DK DK10717531T patent/DK2419741T3/da active
- 2010-04-14 PL PL10717531T patent/PL2419741T3/pl unknown
- 2010-04-14 HU HUE10717531A patent/HUE046182T2/hu unknown
- 2010-04-14 CN CN201510626744.9A patent/CN105334330A/zh active Pending
- 2010-04-14 CN CN201080016849.8A patent/CN102395888B/zh active Active
- 2010-04-14 SI SI201031945T patent/SI2419741T1/sl unknown
- 2010-04-14 WO PCT/EP2010/002279 patent/WO2010118855A1/en not_active Ceased
- 2010-04-14 ES ES10717531T patent/ES2751105T3/es active Active
- 2010-04-14 US US13/264,252 patent/US9046532B2/en active Active
- 2010-04-14 HR HRP20191862TT patent/HRP20191862T1/hr unknown
- 2010-04-14 EP EP10717531.7A patent/EP2419741B1/en not_active Revoked
- 2010-04-14 LT LT10717531T patent/LT2419741T/lt unknown
- 2010-04-14 PT PT107175317T patent/PT2419741T/pt unknown
-
2015
- 2015-03-30 US US14/672,801 patent/US9810699B2/en active Active
-
2016
- 2016-08-16 HK HK16109795.0A patent/HK1221766A1/zh unknown
-
2017
- 2017-11-06 US US15/804,282 patent/US20180052179A1/en not_active Abandoned
-
2019
- 2019-10-24 CY CY20191101107T patent/CY1122202T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HK1221766A1 (zh) | 2017-06-09 |
| WO2010118855A1 (en) | 2010-10-21 |
| HRP20191862T1 (hr) | 2019-12-27 |
| EP2419741A1 (en) | 2012-02-22 |
| HUE046182T2 (hu) | 2020-02-28 |
| CN102395888B (zh) | 2017-05-03 |
| PL2419741T3 (pl) | 2020-01-31 |
| JP2012523573A (ja) | 2012-10-04 |
| CY1122202T1 (el) | 2020-11-25 |
| LT2419741T (lt) | 2019-11-11 |
| EP2419741B1 (en) | 2019-07-31 |
| US9810699B2 (en) | 2017-11-07 |
| JP5650718B2 (ja) | 2015-01-07 |
| US20180052179A1 (en) | 2018-02-22 |
| US20120100635A1 (en) | 2012-04-26 |
| US20150247871A1 (en) | 2015-09-03 |
| ES2751105T3 (es) | 2020-03-30 |
| US9046532B2 (en) | 2015-06-02 |
| SI2419741T1 (sl) | 2019-12-31 |
| PT2419741T (pt) | 2019-11-04 |
| CN105334330A (zh) | 2016-02-17 |
| CN102395888A (zh) | 2012-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2222272T3 (da) | Behandling af luftvejssygdom | |
| DK2477592T3 (da) | Rollatorkørestol | |
| PT2528946T (pt) | Métodos de tratamento de doenças autoimunes com antagonistas de dll4 | |
| PL2442814T3 (pl) | Bifidobacteria do leczenia cukrzycy i pokrewnych chorób | |
| EP2489334A4 (en) | MEDICAL STENT | |
| BR112012020050A2 (pt) | acessório ocular iluminado | |
| DK2488242T3 (da) | Medicinsk indåndingsmaske | |
| DK3192520T3 (da) | Terapeutiske midler til reducering af niveauerne af parathyreoideahormon | |
| DK2540238T3 (da) | Specialbyggede patientspecifikke ortopædiske stiftføringer | |
| BRPI0908026A2 (pt) | Métodos para o tratamento de doenças do intestino | |
| EP2568925A4 (en) | PROSTHETIC HEARTLAP WITH LOW GRADIENT | |
| EP2675377A4 (en) | ORTHOPEDIC COMPRESSION PLATE | |
| HUE045367T2 (hu) | Kombinált terápia diabétesz kezelésére | |
| DK2627345T3 (da) | Formuleringer til behandling af sygdomme i de øvre luftveje | |
| SG11201402358RA (en) | Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for use in therapy of an acute disease or acute condition of a patient for stabilizing the circulation | |
| EP2424476A4 (en) | RETINA GRAFT | |
| BRPI1006504A2 (pt) | fralda descartavel | |
| HRP20190171T1 (hr) | Udobna ortopedska stolica za prevenciju bolesti kralježnice | |
| EP2376908A4 (en) | SIMULATION OF NORMAL FRESH THROMBOCYTES | |
| DK2903629T3 (da) | Antistofkonjugat til anvendelse ved behandling af inflammatorisk tarmsygdom | |
| EP2563395A4 (en) | TREATMENT WITH ANTI-S1P ANTIBODY OF PATIENTS WITH OCULAR DISEASES | |
| DK2419741T3 (da) | Risikovurdering af antibiotikabehandling af patienter, der lider af primær ikke-infektiøs sygdom, ved bestemmelse af niveauet af procalcitonin | |
| HUE053229T2 (hu) | FK506 alkalmazása pulmonális artériás hipertenzió kezelésére | |
| PL2467140T3 (pl) | Lapatynib do leczenia raka | |
| IT1401767B1 (it) | Calzatura per la correzione di difetti anatomici o della deambulazione. |